Accelerate is VP MED Group's strategic practice for MedTech innovators. We help founders, engineers and the investors backing them turn validated technology into adopted technology — faster.
Not because the technology is wrong, but because the adoption strategy is.
Between regulatory approval and clinical adoption sits a chasm that destroys more MedTech value than any other single factor. Founders build excellent products and then stall at the moment hospitals, clinicians and procurement teams need to say yes.
Clinical evidence alone does not drive adoption. Behavioural, economic and operational forces matter equally — and most teams discover this too late, after runway has been spent on the wrong things.
Accelerate is the practice that maps the chasm and walks founders across it.
Built inside VP MED Group — a UK MedTech distributor and education business with over two decades of operational experience inside the adoption ecosystem.
A structured methodology that takes a technology from concept validation through to market-entry execution — with defined deliverables and decision gates at every phase.
A facilitated session that surfaces the clinical, commercial and behavioural forces shaping adoption — and converts them into a prioritised action plan.
Our proprietary lens for understanding why promising technologies stall between validation and use — and what it takes to cross.
Modular. Founders engage at any phase. Each phase has defined deliverables, decision gates and commercial milestones.
From concept to clinical adoption · Modular entry · Commercial milestones at every gate
We’ve walked this road with founders navigating NHS procurement, clinical champions, health-economic models and global market access. You don’t need another consultant. You need people who work inside the adoption ecosystem every day.
Adoption risk is the new technology risk. We give investment teams a structured view of commercial readiness before a cheque is written — and a trusted partner to call after.
VP MED Group has supplied and supported innovative medical technologies in UK hospitals since 2003.
We engage with the same clinicians, procurement teams and IDS leads your advisory clients are trying to reach.
An existing infrastructure delivering masterclasses, webinars and structured learning to thousands of MedTech professionals.
Our distribution business depends on us understanding how devices actually get adopted — not how they’re supposed to.
Tell us about the technology, the team or the portfolio you’re trying to move forward. We’ll come to the call with a first-pass adoption diagnostic — no obligation, no slides.